Bank of Nova Scotia’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18M Buy
38,031
+12,749
+50% +$6.42M 0.03% 317
2025
Q4
$11.8M Buy
25,282
+4,227
+20% +$1.96M 0.02% 447
2025
Q3
$8.97M Buy
21,055
+2,506
+14% +$971K 0.02% 438
2025
Q2
$7.11M Sell
18,549
-513
-3% -$185K 0.01% 446
2025
Q1
$6.59M Sell
19,062
-105,670
-85% -$34M 0.01% 418
2024
Q4
$37.4M Buy
124,732
+71,441
+134% +$25M 0.07% 207
2024
Q3
$21.7M Buy
53,291
+32,888
+161% +$12M 0.04% 224
2024
Q2
$6.56M Sell
20,403
-49,371
-71% -$16M 0.01% 424
2024
Q1
$23.3M Sell
69,774
-43,022
-38% -$13.1M 0.05% 246
2023
Q4
$30.5M Buy
112,796
+40,790
+57% +$10.1M 0.06% 226
2023
Q3
$17.7M Buy
72,006
+55,235
+329% +$15.1M 0.05% 237
2023
Q2
$5.09M Buy
16,771
+2,145
+15% +$596K 0.01% 366
2023
Q1
$3.86M Sell
14,626
-3,173
-18% -$806K 0.01% 419
2022
Q4
$4.27M Sell
17,799
-366
-2% -$82K 0.01% 496
2022
Q3
$3.34M Sell
18,165
-928
-5% -$185K 0.01% 512
2022
Q2
$3.21M Sell
19,093
-15,199
-44% -$3.27M 0.01% 585
2022
Q1
$8.6M Sell
34,292
-68,557
-67% -$17.2M 0.01% 484
2021
Q4
$26.4M Buy
102,849
+51,974
+102% +$12.7M 0.04% 335
2021
Q3
$12.3M Buy
50,875
+14,619
+40% +$3.57M 0.02% 436
2021
Q2
$7.5M Sell
36,256
-76,696
-68% -$15.6M 0.01% 501
2021
Q1
$21.3M Buy
112,952
+73,322
+185% +$12.9M 0.04% 290
2020
Q4
$6.52M Sell
39,630
-691,735
-95% -$101M 0.01% 446
2020
Q3
$91.2M Sell
731,365
-83,378
-10% -$10.3M 0.25% 95
2020
Q2
$79.1M Buy
814,743
+314,609
+63% +$32.7M 0.27% 84
2020
Q1
$44.9M Buy
500,134
+232,711
+87% +$30.1M 0.15% 127
2019
Q4
$39.5M Buy
267,423
+213,600
+397% +$28.7M 0.1% 188
2019
Q3
$6.48M Sell
53,823
-121,973
-69% -$15.8M 0.02% 449
2019
Q2
$23.8M Sell
175,796
-7,075
-4% -$895K 0.1% 197
2019
Q1
$23.8M Sell
182,871
-374,555
-67% -$50.3M 0.09% 212
2018
Q4
$69.4M Buy
557,426
+465,293
+505% +$62.5M 0.32% 73
2018
Q3
$12.8M Buy
92,133
+61,432
+200% +$7.65M 0.06% 273
2018
Q2
$3.15M Sell
30,701
-5,009
-14% -$507K 0.02% 414
2018
Q1
$3.46M Sell
35,710
-8,864
-20% -$860K 0.02% 452
2017
Q4
$3.92M Sell
44,574
-5,470
-11% -$439K 0.02% 446
2017
Q3
$3.98M Sell
50,044
-14,609
-23% -$1.17M 0.02% 420
2017
Q2
$5.64M Sell
64,653
-1,441
-2% -$122K 0.03% 407
2017
Q1
$5.88M Buy
66,094
+59,480
+899% +$4.96M 0.03% 388
2016
Q4
$490K Buy
6,614
+500
+8% +$37.4K ﹤0.01% 613
2016
Q3
$462K Buy
6,114
+20
+0.3% +$1.53K ﹤0.01% 538
2016
Q2
$469K Buy
6,094
+220
+4% +$17.4K ﹤0.01% 507
2016
Q1
$458K Sell
5,874
-175,050
-97% -$12.2M ﹤0.01% 494
2015
Q4
$12.2M Buy
180,924
+174,980
+2,944% +$12.2M 0.06% 161
2015
Q3
$460K Buy
5,944
+704
+13% +$62.3K ﹤0.01% 444
2015
Q2
$475K Buy
5,240
+40
+0.8% +$3.21K ﹤0.01% 376
2015
Q1
$391K Sell
5,200
-124,800
-96% -$8.96M ﹤0.01% 417
2014
Q4
$9.54M Buy
+130,000
New +$9.14M 0.04% 159
2014
Q3
Sell
-300,000
Closed -$16.9M 572
2014
Q2
$16.9M Buy
+300,000
New +$15.8M 0.07% 118

Other funds holding HCA

Bank of Nova Scotia's HCA Position: Q1 2026 in Review

Bank of Nova Scotia increased its HCA Healthcare (HCA) stake by 50% in Q1 2026, buying an estimated $6.42M and bringing the position to 38,031 shares worth $18M. The position accounts for 0.03% of the portfolio, ranked #317.

Bank of Nova Scotia first reported a position in HCA in Q2 2014 and has held it in 47 quarters since. The position peaked at $91.2M in Q3 2020. 1,415 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Bank of Nova Scotia held 38,031 shares of HCA Healthcare worth $18M as of Q1 2026.
  • Bank of Nova Scotia bought 12,749 HCA Healthcare shares in Q1 2026, an estimated $6.42M.
  • HCA Healthcare made up 0.03% of Bank of Nova Scotia's portfolio in Q1 2026, its #317 holding.
  • Bank of Nova Scotia first reported a position in HCA Healthcare in Q2 2014 and has held it in 47 quarters since.
  • Bank of Nova Scotia's HCA Healthcare position peaked at $91.2M in Q3 2020.
  • 1,415 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Bank of Nova Scotia's 13F filing for Q1 2026, filed 14 May 2026.